Growing Heart Problems Forces CDC to Change Vaccine Schedule

The Centers for Disease Control and Prevention (CDC) on Feb. 4 outlined an expected change to the COVID-19 vaccine schedule for people with weak immune systems and signaled that a different alteration is coming for the general population to try to cut the number of post-vaccination heart inflammation cases.

The CDC told its vaccine advisory panel that it’s planning to adjust guidance for people with compromised immune systems, a group that doesn’t respond as well to vaccines as the general population and is the only population that is advised to get four doses of the Moderna or Pfizer messenger RNA (mRNA) vaccines.

Current CDC guidance for the immunocompromised says they should receive three doses of an mRNA vaccine within two months, and a fourth dose at least five months after the third dose.

The revised schedule would recommend the population get that fourth shot as soon as three months after their third one.

For recipients in the population who received the single-shot Johnson & Johnson COVID-19 vaccine, the updated guidance says they should get a second dose at least 28 days after their vaccination, and a third dose as soon as two months later.

The guidance update applies to people 18 and older who received the Johnson & Johnson or Moderna vaccines, and people 12 and up who received the Pfizer jab.

The rationale for the adjustment includes small studies that indicate the immunocompromised are better protected if they get the fourth shot sooner, Elisha Hall, a health education specialist at the CDC, told the panel, the Advisory Committee on Immunization Practices.

The goal is “to help this population that may not be as well protected get their booster dose sooner, particularly with concerns about initial immune response, loss of protection over time, and high community transmission due to the Omicron variant,” she said.

Omicron is the dominant variant of the CCP (Chinese Communist Party) virus in the United States. The CCP virus causes COVID-19.

The vaccines already were waning in protection over time against infection while the Delta variant was dominant in the country, and have performed even worse against the Omicron strain.

Dr. Camille Kotton, an infectious disease expert at Massachusetts General Hospital and a panel member, said she had seen many immunocompromised patients in the past two months who “followed all the rules,” including the recommended vaccination schedule, but still became infected with the virus.

The updated guidance “will help dramatically,” she said.

The other likely change would apply to the general public and deals with the length of time that elapses between the first and second shot of the mRNA vaccines. Both have a two-dose primary schedule.

At present, the second Pfizer dose is recommended around 21 days after the first, and the second Moderna dose is recommended around 28 days after the initial shot. However, surveillance data show that among many age groups, particularly young males, who have received the vaccines, there has been a higher than expected rate of heart inflammation.

Data from Canada and England, which have both extended the interval, suggest an extended time period between the first and second doses increased vaccine effectiveness and lowered rates of myocarditis and pericarditis, two forms of heart inflammation that have cropped up following mRNA vaccination.

“The longer interval resulted in lower myocarditis rates, whereas the shorter interval had higher myocarditis and pericarditis rates,” said Dr. Bryna Warshawsky of the Public Health Agency of Canada.

Dr. Grace Lee, a medical officer at the Lucile Packard Children’s Hospital and the advisory panel’s chair, said the data presented “are fairly convincing that an extended interval is not only potentially safer from a myocarditis standpoint, but also potentially more effective.”

The data pertain to when Delta was the dominant variant in much of the world. Omicron displaced Delta in December 2021 in the United States.

Some countries have halted or curtailed the use of the mRNA vaccines, particularly Moderna’s, among youths due to the heart inflammation issues, but U.S. health authorities have so far continued to recommend the shots for all Americans 5 and older, asserting the vaccines prevent more hospitalizations than the heart inflammation cases they cause.

The panel’s COVID-19 vaccines working group, after analyzing altered vaccine schedules from various countries, endorsed an interval of eight weeks between the first and second dose of an mRNA vaccine primary series. The CDC hasn’t yet decided whether to follow the advice.

If changed, the revised schedule could affect millions of people. Some 33 million Americans aged 12 to 39 remain unvaccinated, as well as tens of millions of Americans in older age groups. It would also push back booster shots, which are currently recommended five months after the Moderna or Pfizer primary series, and two months after the initial Johnson & Johnson shot.

Dr. Walid Gellad, a professor of medicine at the University of Pittsburgh, called the expected change “a big deal.”

At the same time, it is “troubling” that it “took so long for US policymaking to catch up to other countries,” Gellad, who is not on the panel, wrote on Twitter.

Panel members said they hoped the change would help convince unvaccinated people to get a jab.

“I think that it affords a level of safety and also demonstrates to the public that we are very focused on doing this in the right way,” said Dr. Oliver Brooks, chief medical officer of Watts HealthCare Corp.

See more here: theepochtimes.com

Header image: Reuters

Please Donate Below To Support Our Ongoing Work To Expose The Lies About COVID19

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.

Comments (7)

  • Avatar

    very old white guy

    |

    How about stopping the lies and the shots. They are needed as they do not work and are killing people by the tens of thousands.

    Reply

    • Avatar

      very old white guy

      |

      no way to edit??? They are “not” needed…..

      Reply

    • Avatar

      Charles Higley

      |

      I love the J&J and AstraZeneca schedule. As they are virus-based jabs, a person will develop antibodies against the adenovirus as well as the spike protein. Giving a second or third dose means that the body will attack the jab automatically. They are mostly used to introduce, by “transfection,” genetic material into cells in cell cultures.

      Reply

  • Avatar

    richard

    |

    MArch 2019 – “Therefore, mRNA holds great promises, but further insights into the mechanism of action and potency are still needed for full development of mRNA vaccines….

    ….As described above, the molecular impact of the innate immune response stimulated by mRNA through PAMP recognition is still not clear. Multiple efforts have been made to improve the stability and delivery efficiency of in vivo mRNA vaccine, including incorporation of 5′ and 3′ terminal untranslated regions and chemically modified nucleosides (162–164)”
    ….Although mRNA vaccine technology has still not extensively tested in humans, publications of preclinical and early clinical tests have emerged in recent years, in which promising results were reported. This evoked the momentum of biocompanies to commercialize mRNA vaccines with great enthusiasm (167, 168). Some private funding resources and institutes have supported the research and development of mRNA vaccines (169, 170). Despite the need for further optimization of manufacturing processes to generate mRNA vaccines, these processes hopefully will be streamlined to be establish large-scale production. It is just a matter of time for RNA vaccines to be used in humans and animals”

    I feel sorry for the guinea pigs that have taken it .

    Reply

    • Avatar

      Charles Higley

      |

      Actually three mRNA “vaccines” for HIV and Ebola have been trialed in Africa and all these studies terminated for making the subjects sick from the given disease meant to be vaccinated for. The death rates (as high as 50%) were unacceptable and the studies stopped. Where is that promising results, unless your goal is to kill people?

      No mRNA “vaccine” (it is not a vaccine but gene therapy) has been approved ever. And now they approve four essentially simultaneously? This is wrong and patently dangerous in every way.

      Reply

  • Avatar

    Ken Hughes

    |

    All this seems pathetically stupid when you realise the vaccines are not there to help us, they’re there to kill us.

    Reply

  • Avatar

    Tom

    |

    Thank you dear CDC…after you have already murdered 10’s of thousands. Didn’t you bums get the memo? There are no viruses so your agency can be shut down and more people will survive without your useless nonsense.

    Reply

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
Share via